EIN 13-1930701

Cystic Fibrosis Foundation

IRS 501(c) type
501(c)(3)
Num. employees
888
Year formed
1955
Most recent tax filings
2019-12
Description
The mission of the Cystic Fibrosis Foundation is to cure Cystic Fibrosis and to provide all people with the disease the opportunity to lead full, productive lives by funding research and drug development, promoting individualized treatment, and ensuri...

Program areas at Cystic Fibrosis Foundation

Medical programs - since 1955, the Cystic Fibrosis Foundation has been dedicated to curing and controlling Cystic Fibrosis (cf). The Cystic Fibrosis Foundation is the world's leader in the search for a cure for Cystic Fibrosis, a life-threatening genetic disease that affects more than 30,000 people in the united states, and 70,000 worldwide. The Foundation accomplishes its mission by funding life-saving research to discover and develop effective therapies for people with cf. The cf Foundation has funded hundreds of millions of dollars of research costs to help discover/develop cf drugs and therapies. Through the Foundation's efforts, the life expectancy of people with cf has more than doubled in the last 30 years, and research to find a cure is more promising than ever before. In 2019, the cf Foundation invested $201 million into research and care. The cf Foundation has attracted significant industry involvement in the fight against cf by funding contracted drug discovery and development research conducted by biotechnology companies. It also provides matching awards to cf drug developers for cf research and funds a specialized cf clinical trials network of nearly 90 foundation-accredited care centers. As a result of this funding, in 2019 the cf drug development pipeline had 29 therapies in development in addition to 15 fda approved treatments that address complications like infections and a potential cure. The treatment and care protocols developed by the cf Foundation are helping tens of thousands of people with the disease live longer, healthier lives. To support its mission, the Foundation funds and accredits a nationwide network of more than 130 care centers. The care center network provides the best care for people with cf and has been recognized by the national institutes of health as a model of care for a chronic disease. In 2019, the Foundation provided more than $41 million of support for care centers and clinicians. The Foundation's patient registry collects information on the health status of more than 31,199 people with cf, providing caregivers and researchers critical information to help identify new health trends and effective treatments and improve the quality of cf care. The patient registry is an internationally recognized model for other nonprofit health organizations, including cf advocacy groups.
Public and professional information and education - to broaden its reach and to support its mission, the cf Foundation has programs designed to improve the knowledge of people with cf and their families, medical professionals and the general public regarding the disease. In 2019, there were 27 publications and 39 videos produced and made available to support education and awareness. Year-round, meetings and conferences provide updates for cf researchers, physicians and allied health professionals and opportunities for collaboration on future cf research projects and treatment/care efforts. In 2019, over 3,063,346 unique visitors came to the cf Foundation's website. New content on cff.org in 2019 included the launch of 11 new sections and 90 blog posts.
Community services - the Foundation provides much-needed support for patients and their families as they manage the physical, emotional, and financial challenges of living with cf - from supporting specialized quality cf care, to providing information and resources to help people with cf become effective partners in their care to programs to help affect the isolation of living with this disease. Approximately 31,199 people with cf were served in 2019, including approximately 766 individuals who were newly diagnosed. Lack of adequate insurance coverage for cf medications has been a consistent concern for those living with the disease and their families. Compass is a highly personalized service tailored to an individual's circumstances related to complex insurance, financial, legal, and other issues that can prevent access to much-needed cf therapies and care. In 2019, skilled case managers addressed more than 6,000 cases for people with cf, their families, and their provider network, including understanding and maximizing their insurance coverage and benefits, as well as getting help with other needs related to daily life with cf. Case managers also assisted with finding resources for issues related to life with cf that can affect access, including basic living and food expenses. Today, more than half of all people with cf are age 18 or older. In 2019, approximately 1,500 people with cf and their family members joined virtual events designed by and for adults with cf, family, clinicians and researchers including breathecon, familycon and researchcon, that provide an opportunity for the cf community to connect, share, and learn from peers through open and honest dialogue.

Form 990s for Cystic Fibrosis Foundation

Fiscal year endingDate received by IRSFormPDF link
2019-122021-02-22990View PDF
2018-122019-12-05990View PDF
2017-122018-11-15990View PDF
2016-122017-10-19990View PDF
2015-122016-12-12990View PDF
...and 6 more Form 990s

Who funds Cystic Fibrosis Foundation

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Fidelity Investments Charitable Gift FundFor Grant Recipient's Exempt Purposes$1,764,820
 Subscribe to view███$999,999
 Subscribe to view█ ████ █ █████ ██ ██████ ████ █ ██ ███ █ ███ █████$999,999
...and 800 more grants received

Grants made by Cystic Fibrosis Foundation

GranteeGrant descriptionAmount
Seattle Children's HospitalClinical Research$9,086,103
 Subscribe to view████ ████ ███$9,999,999
 Subscribe to view████ ██████$9,999,999
 Subscribe to view████ █████$9,999,999
 Subscribe to view████ ██ ████$9,999,999
...and 476 more grants made

Financials for Cystic Fibrosis Foundation

RevenuesFYE 12/2019
Total grants, contributions, etc.$108,894,890
Program services$4,147,243
Investment income and dividends$73,149,393
Tax-exempt bond proceeds$0
Royalty revenue$44,535,937
Net rental income$0
Net gain from sale of non-inventory assets$368,640,932
Net income from fundraising events$0
Net income from gaming activities$126,193
Net income from sales of inventory$0
Miscellaneous revenues$6,283,837
Total revenues$605,778,425

Personnel at Cystic Fibrosis Foundation

NameTitleCompensation
Preston CampbellPresident and Chief Executive Officer$1,296,038
Marc S GinskyExecutive Vice President , Chief Operating Officer and Secretary$798,697
Jack MahlerChief Investment Officer$1,129,788
 Subscribe to viewExecutive Vice President and Chief Financial Officer$616,492
 Subscribe to viewChief Information Officer
...and 12 more key personnel

Organizations like Cystic Fibrosis Foundation

OrganizationLocationRevenue
National Multiple Sclerosis SocietyNew York, NY$196,889,837
Juvenile Diabetes Research Foundation (JDRF)New York, NY$239,329,465
Alzheimer's AssociationChicago, IL$403,087,006
The Leukemia and Lymphoma SocietyRye Brook, NY$496,221,309
American Cancer Society (ACS)Atlanta, GA$720,131,846
The Michael J. Fox Foundation for PARKINSON'S ResearchNew York, NY$161,693,487
Fred Hutch (FHCRC)Seattle, WA$698,140,612
Dana-Farber Cancer InstituteBoston, MA$1,985,509,644
Be the MatchMinneapolis, MN$445,357,123
Scripps Research InstituteLa Jolla, CA$412,183,981
Salk Institute for Biological StudiesLa Jolla, CA$189,316,467
American Heart Association (AHA)Dallas, TX$746,432,389
Population Services International (PSI)Washington, DC$493,614,976
Beckman Research Institute of the City of Hope (BRI)Duarte, CA$568,398,026
Mtfbiologics (MTF)Edison, NJ$460,828,632
The Broad InstituteCambridge, MA$536,846,609
Henry M Jackson Foundation For The Advancement of Military MedicineBethesda, MD$495,039,325
Beth Israel Deaconess Medical Center (BIDMC)Boston, MA$1,945,120,516
Cold Spring Harbor LaboratoryCold Spring Harbor, NY$307,604,088
Purdue Research Foundation (PRF)West Lafayette, IN$212,466,003
Loyola University Medical Center (LUMC)Maywood, IL$1,451,869,584
Wounded Warrior ProjectJacksonville, FL$282,456,768
Dartmouth-Hitchcock (D-H)Lebanon, NH$1,389,836,528
Wildlife Conservation SocietyBronx, NY$263,863,758
Evangelical Lutheran Good Samaritan SocietySioux Falls, SD$964,398,144
Nonprofit Types
Issues
Characteristics
Key performance indicators
Total revenues
$605,778,425
2019
Yearly growth
119.7%
% of revenues
n/a
Total expenses
$348,650,099
2019
Yearly growth
3.2%
% of expenses
n/a
Total assets
$4,476,511,082
2019
Yearly growth
11.5%
% of assets
n/a
Num. employees
888
2019
Yearly growth
5%
% of total
n/a
General information
Address
4550 MONTGOMERY AVENUE Suite 1100N
Bethesda, MD 20814
Metro area
Washington-Arlington-Alexandria, DC-VA-MD-WV
Website URL
cff.org/ 
Phone
(301) 951-4422
Facebook page
cysticfibrosisfoundation 
Twitter profile
@cf_foundation 
IRS details
EIN
13-1930701
Fiscal year end
December
Taxreturn type
Form 990
Year formed
1955
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
G12: Voluntary Health Associations and Medical Disciplines Fund Raising and Fund Distribution
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent